Diagnosis and management of bronchiectasis
- PMID: 28630359
- PMCID: PMC5478409
- DOI: 10.1503/cmaj.160830
Diagnosis and management of bronchiectasis
Abstract
KEY POINTS Following a diagnosis of bronchiectasis, it is important to investigate for an underlying cause. Goals of management are to suppress airway infection and inflammation, to improve symptoms and health-related quality of life. There are now validated scoring tools to help assess disease severity, which can help to stratify management. Good evidence supports the use of both exercise training and long-term macrolide therapy in long-term disease management.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Management of bronchiectasis in adults.Eur Respir J. 2015 May;45(5):1446-62. doi: 10.1183/09031936.00119114. Epub 2015 Mar 18. Eur Respir J. 2015. PMID: 25792635 Review.
-
Non-cystic fibrosis bronchiectasis.Am J Respir Crit Care Med. 2013 Sep 15;188(6):647-56. doi: 10.1164/rccm.201303-0411CI. Am J Respir Crit Care Med. 2013. PMID: 23898922 Review.
-
Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults.NPJ Prim Care Respir Med. 2017 Mar 13;27(1):18. doi: 10.1038/s41533-017-0019-9. NPJ Prim Care Respir Med. 2017. PMID: 28270656 Free PMC article. Review.
-
Bronchiectasis: new approaches to diagnosis and management.Clin Chest Med. 2011 Sep;32(3):535-46. doi: 10.1016/j.ccm.2011.05.002. Clin Chest Med. 2011. PMID: 21867821 Review.
-
Emerging drugs for bronchiectasis.Expert Opin Emerg Drugs. 2012 Sep;17(3):361-78. doi: 10.1517/14728214.2012.702755. Epub 2012 Jul 19. Expert Opin Emerg Drugs. 2012. PMID: 22809423 Review.
Cited by
-
Factors influencing survival and mortality among adult Aboriginal Australians with bronchiectasis-A 10-year retrospective study.Front Med (Lausanne). 2024 May 7;11:1366037. doi: 10.3389/fmed.2024.1366037. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38774399 Free PMC article.
-
Evidence-based management guidelines for noncystic fibrosis bronchiectasis in children and adolescents.Clin Exp Pediatr. 2024 Sep;67(9):418-426. doi: 10.3345/cep.2023.00871. Epub 2024 Jan 23. Clin Exp Pediatr. 2024. PMID: 38271987 Free PMC article.
-
Non-cystic fibrosis bronchiectasis: A single-centre retrospective study in Johannesburg, South Africa.Afr J Thorac Crit Care Med. 2023 Nov 27;29(4):e1017. doi: 10.7196/AJTCCM.2023.v29i4.1017. eCollection 2023. Afr J Thorac Crit Care Med. 2023. PMID: 38239779 Free PMC article.
-
Microbiology sampling in non-cystic fibrosis bronchiectasis cases from northern Alberta.PLoS One. 2023 Jul 14;18(7):e0288704. doi: 10.1371/journal.pone.0288704. eCollection 2023. PLoS One. 2023. PMID: 37450508 Free PMC article.
-
Daily versus three-times-weekly azithromycin in Chinese patients with non-cystic fibrosis bronchiectasis: protocol for a prospective, open-label and randomised controlled trial.BMJ Open. 2022 Jul 8;12(7):e059186. doi: 10.1136/bmjopen-2021-059186. BMJ Open. 2022. PMID: 35803624 Free PMC article.
References
-
- King PT, Holdsworth SR, Freezer NJ, et al. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med 2006;100:2183–9. - PubMed
-
- Martínez-García MA, Perpiñá-Tordera M, Román-Sánchez P, et al. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest 2005; 128:739–45. - PubMed
-
- Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000;162:1277–84. - PubMed
-
- Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med 2007;101:1163–70. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources